Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK.

Saved in:
Bibliographic Details
Title: Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK.
Authors: Aladul, Mohammed, Fitzpatrick, Raymond1, Chapman, Stephen1 s.r.chapman@keele.ac.uk
Source: BioDrugs. Dec2017, Vol. 31 Issue 6, p533-544. 12p.
Database: Academic Search Ultimate
Description
ISSN:11738804
DOI:10.1007/s40259-017-0252-3